BioCryst Pharmaceuticals BCRX Business Segments — Other Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherIncome.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's business segments — other income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's business segments — other income?
- BioCryst Pharmaceuticals (BCRX) reported business segments — other income of -$1.46M in Q1 2026.
- What does business segments — other income mean?
- Includes non-operating income streams that do not fall under core revenue or interest income, such as gains from asset disposals or miscellaneous settlements. It provides insight into peripheral financial activities that impact the bottom line.